HI
PFE icon

Harbour Investments’s Pfizer PFE Stock Holding History

Harbour Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4M Sell
141,011
-2,419
-2% -$63.3K 0.05% 364
2026
Q1 		$4.03M Buy
143,430
+45,601
+47% +$1.21M 0.06% 283
2025
Q4 		$2.44M Buy
97,829
+20,136
+26% +$508K 0.05% 340
2025
Q3 		$1.98M Buy
77,693
+11,114
+17% +$274K 0.04% 353
2025
Q2 		$1.61M Buy
66,579
+232
+0.3% +$5.41K 0.04% 380
2025
Q1 		$1.68M Buy
66,347
+3,655
+6% +$95.6K 0.05% 341
2024
Q4 		$1.66M Sell
62,692
-10,341
-14% -$280K 0.05% 331
2024
Q3 		$2.11M Sell
73,033
-254
-0.3% -$7.41K 0.06% 262
2024
Q2 		$2.05M Buy
73,287
+9,216
+14% +$254K 0.07% 248
2024
Q1 		$1.78M Buy
64,071
+7,147
+13% +$198K 0.06% 279
2023
Q4 		$1.64M Sell
56,924
-4,292
-7% -$130K 0.07% 267
2023
Q3 		$2.03M Buy
61,216
+3,507
+6% +$124K 0.1% 193
2023
Q2 		$2.12M Buy
57,709
+450
+0.8% +$17.5K 0.1% 190
2023
Q1 		$2.34M Buy
57,259
+4,205
+8% +$182K 0.13% 149
2022
Q4 		$2.72M Buy
53,054
+3,699
+7% +$177K 0.17% 120
2022
Q3 		$2.59M Hold
49,355
– – 0.17% 108
2022
Q2 		$2.59M Buy
+49,355
New +$2.52M 0.17% 108
2021
Q4 		$2.75M Sell
46,575
-75,187
-62% -$3.73M 0.16% 123
2021
Q3 		$5.24M Sell
121,762
-6,981
-5% -$309K 0.17% 113
2021
Q2 		$5.04M Buy
128,743
+3,560
+3% +$138K 0.16% 122
2021
Q1 		$4.54M Buy
+125,183
New +$4.44M 0.16% 124

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Harbour Investments's PFE Position: Q2 2026 in Review

Harbour Investments reduced its Pfizer (PFE) stake by 1.7% in Q2 2026, selling an estimated $63.3K and leaving 141,011 shares worth $3.4M. The position accounts for 0.05% of the portfolio, ranked #364.

Harbour Investments first reported a position in PFE in Q1 2021 and has held it in 21 quarters since. The position peaked at $5.24M in Q3 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Harbour Investments held 141,011 shares of Pfizer worth $3.4M as of Q2 2026.
  • Harbour Investments sold 2,419 Pfizer shares in Q2 2026, an estimated $63.3K.
  • Pfizer made up 0.05% of Harbour Investments's portfolio in Q2 2026, its #364 holding.
  • Harbour Investments first reported a position in Pfizer in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Pfizer position peaked at $5.24M in Q3 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.